Báo cáo này đầy đủ thông tin về ngành Dược phẩm và sản phẩm chăm sóc sức khỏe ở Việt Nam trong 5 năm qua và dự báo đến 2019. Trong đó có cả thông tin về thị phần của các DN sản xuất thuốc hàng đầu Việt Nam

CONTENTS

1.Executive Summary

Vietnam Pharmaceutical And Healthcare Industry SWOT

Vietnam Political Swot

Vietnam Economic Swot

Vietnam Business Environment Swot

2. Vietnam – Business Environment Ratings

Table: Asia Pacific Pharmaceutical Business Environment Ratings For Q110

Limits Of Potential Returns

Risks To Realisation Of Returns

3. Market Summary

4. Regulatory Regime

Pharmaceutical Advertising

Intellectual Property Environment

IP Shortcomings

Counterfeit Drugs

Other Regulatory Issues

Pricing And Reimbursement Regime

5. Industry Trends And Developments

Epidemiology

Healthcare Financing

Healthcare Insurance

Healthcare And Pharmaceutical Reforms

Foreign Partnerships

Domestic Pharmaceutical Sector

Foreign Pharmaceutical Sector

Traditional Medicines

Retail Sector

Table: Key Aspects Of Good Pharmacy Practice (GPP) In Developing Countries

Research And Development

Vaccine Sector

Biotechnology Sector

6. Industry Forecast Scenario

Overall Market Forecast

Key Growth Factors – Industry

Key Growth Factors – Macroeconomic

Economic Activity

Vietnam – Economic Activity, 2007-2014

Prescription Drug Market Forecast

OTC Medicine Market Forecast

Patented Product Market Forecast

Generic Drug Market Forecast

Pharmaceutical Trade Forecast

Medical Device Market Forecast

Other Healthcare Data Forecasts

Key Risks To BMI’s Forecast Scenario

7. Competitive Landscape

Company Profiles

Leading Multinational Manufacturers

Pfizer

Sanofi-Aventis

Novartis

Merck & Co

Indigenous Manufacturer Profiles

Vietnam Pharmaceutical Corporation (Vinapharm)

Vietnam OPV Pharmaceutical Co

Vietnam Pharmaceutical Joint Stock Company (Ampharco)

Vidipha Central Pharmaceutical Joint Stock Company

8. Country Snapshot: Vietnam Demographic Data

9. Forecast Table